Next |
home / stock / ptie / ptie message board
Subject | By | Source | When |
---|---|---|---|
May 2023 Corp Presentation: | FooBarAndGrill | investorshub | 05/01/2023 2:21:06 PM |
Enrollment rate: ~125/mo. | FooBarAndGrill | investorshub | 05/01/2023 2:18:51 PM |
$SAVA Patent application: SavaDX | FooBarAndGrill | investorshub | 05/01/2023 11:31:54 AM |
Thanks for the updates Foobar. | runncoach | investorshub | 04/27/2023 8:04:12 PM |
Judge stated 2-3 weeks for the dismissal decision. | FooBarAndGrill | investorshub | 04/27/2023 7:19:10 PM |
Sava is the defendant in this hearing scheduled | FooBarAndGrill | investorshub | 04/26/2023 1:18:36 PM |
Although I follow this stock of only a | sab63090 | investorshub | 04/26/2023 8:18:36 AM |
Nothing to be sorry about. Once again | runncoach | investorshub | 04/25/2023 11:56:22 PM |
No idea about that but he is a | Hoskuld | investorshub | 04/25/2023 11:14:07 PM |
No idea about that. What I do know | runncoach | investorshub | 04/25/2023 10:49:03 PM |
He is. I always learn something from his | runncoach | investorshub | 04/22/2023 1:50:17 PM |
Doc328 is truly excellent, a wealth of knowledge | tootalljones | investorshub | 04/22/2023 5:28:07 AM |
Nice little write-up. | FooBarAndGrill | investorshub | 04/04/2023 3:41:15 PM |
Full day on the Judge's schedule. | FooBarAndGrill | investorshub | 03/24/2023 12:24:29 PM |
Cassava Hearing on motion to dismiss. I | FooBarAndGrill | investorshub | 03/23/2023 11:04:28 AM |
Cassava's new 8K is related to/explains Proposal 3 | FooBarAndGrill | investorshub | 03/17/2023 1:14:49 PM |
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS | FooBarAndGrill | investorshub | 03/17/2023 12:33:23 AM |
re. Catalyst | FooBarAndGrill | investorshub | 03/14/2023 8:25:45 PM |
I see the CAPE schiller (pe) is | tootalljones | investorshub | 03/14/2023 7:19:05 PM |
any catalysts for SAVA coming up over the | tootalljones | investorshub | 03/14/2023 6:01:45 PM |
News, Short Squeeze, Breakout and More Instantly...
Pain Therapeutics Inc. Company Name:
PTIE Stock Symbol:
NASDAQ Market:
Pain Therapeutics Inc. Website:
AUSTIN, Texas, March 27, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a drug development company, announced a company name change to Cassava Sciences, Inc., effective immediately. The new name was chosen to better reflect the Company’s strategic focus on ...
AUSTIN, Texas, March 25, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today reported financial results for the year ended December 31, 2018. Net loss in 2018 was $6.6 million, or $0.61 per share, compared to a net loss in 2017 of $11.9 million, or $1.82 per share. Cash us...
AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a clinical-stage drug development company, today announced feedback from a meeting held January 31, 2019 with the U.S. Food and Drug Administration (FDA) regarding the drug candidate, REMOXY ER. R...